Calendar

A Science & Innovation Webinar, presented by Cytokinetics.

• Symptomatic obstructive hypertrophic cardiomyopathy (oHCM) is a chronic, progressive condition affecting 1:200 to 1:500 individuals in the US^1,2
• Despite available standard-of-care therapies, patients may experience impaired functional capacity and disease progression, driving the need for therapies that target the underlying oHCM pathophysiology rather than symptoms alone^2-4
• This webinar will be led by Rachel Lavelle, PharmD, who brings complementary clinical and managed care perspectives on oHCM, combining deep experience in cardiology care, guideline-directed therapy implementation, and value-focused cardiovascular outcomes

A Pre-Approval Information Exchange (PIE) Webinar, presented by Beren Therapeutics P.B.C.

This webinar provides an overview of infantile onset Niemann Pick disease type C, a rare, autosomal recessive neurodegenerative disorder caused by impaired intracellular cholesterol trafficking that leads to progressive neurologic decline and premature death, and discusses emerging clinical evidence for adrabetadex, an investigational therapy designed to re establish cholesterol trafficking. Topics include disease burden, unmet need, clinical and safety results, and managed care implications.

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions.

This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.

An AMCP Webinar, presented by Cencora. Open to healthcare decision-makers only.

Healthcare decision-makers play a critical role in shaping patient access and coverage decisions. This webinar explains how the Cencora team partners with healthcare decision-makers to gather perspectives through structured market research and what to expect if you choose to participate as a panel member.

We will cover the common research formats you may be invited to join (eg, surveys, in-depth interviews, advisory boards), the topics typically explored in market access research, and how participation fits into your schedule. You'll also get inside look at the participant experience, from registration and qualification to fair market value (FMV) determination, study invitations, scheduling, participation, and honoraria timelines.